CytomX Therapeutics (CTMX) Operating Expenses (2014 - 2026)
CytomX Therapeutics' (CTMX) quarterly Operating Expenses came in at $29.9 million in Q1 2026, up 5.77% YoY from $28.3 million in Q1 2025, and up 4.67% on a QoQ basis from $28.6 million in Q4 2025.
CytomX Therapeutics (CTMX) Operating Expenses (2014 - 2026) Analysis & Trends
CytomX Therapeutics (CTMX) has 13 years of Operating Expenses data on file, last reported at $29.9 million in Q1 2026.
- Quarterly Operating Expenses rose 5.77% year-over-year to $29.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $100.2 million (down 10.21% YoY) and the FY2025 annual result came in at $98.6 million, down 12.86% from the prior year.
- Operating Expenses rose to $29.9 million in Q1 2026, from $28.6 million in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $42.9 million in Q2 2022 to a low of $19.9 million in Q2 2025.
- A 5-year average of $29.6 million and a median of $29.2 million in 2023 frame the typical range for Operating Expenses.
- Annual changes were most pronounced in 2023 — Operating Expenses tumbled 43.07% — and 2025, when it surged 40.08%.
- Tracing CTMX's Operating Expenses over 5 years: stood at $29.6 million in 2022, then retreated by 8.16% to $27.2 million in 2023, then retreated by 24.98% to $20.4 million in 2024, then soared by 40.08% to $28.6 million in 2025, then increased by 4.67% to $29.9 million in 2026.
- The last three Operating Expenses figures came in at $29.9 million (Q1 2026), $28.6 million (Q4 2025), and $21.7 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 2.89 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.21 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4,978.15 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 541.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.06 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 427.03 Mn |
| 10 | CytomX Therapeutics | 732.14 Mn | 401.86 Mn | - | 25.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 25.20 Mn |
| Mar 31, 2026 | 29.93 Mn |
| Dec 31, 2025 | 28.60 Mn |
| Sep 30, 2025 | 21.73 Mn |
| Jun 30, 2025 | 19.94 Mn |
| Mar 31, 2025 | 28.30 Mn |
| Dec 31, 2024 | 20.41 Mn |
| Sep 30, 2024 | 29.32 Mn |
| Jun 30, 2024 | 33.57 Mn |
| Mar 31, 2024 | 29.81 Mn |
| Dec 31, 2023 | 27.21 Mn |
| Sep 30, 2023 | 23.26 Mn |
| Jun 30, 2023 | 28.07 Mn |
| Mar 31, 2023 | 29.15 Mn |
| Dec 31, 2022 | 29.63 Mn |
| Sep 30, 2022 | 40.86 Mn |
| Jun 30, 2022 | 42.91 Mn |
| Mar 31, 2022 | 41.10 Mn |
| Dec 31, 2021 | 46.04 Mn |
| Sep 30, 2021 | 40.23 Mn |